社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
不是那么好割的小韭菜
IP属地：未知
+关注
帖子 · 353
帖子 · 353
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-02-23
对比特币真失望这几日比特币的保障暴跌让我对曾经极力看好的比特币彻底改观。比特币的优势如去中心化，匿名性，不受全球央行控制等完全没有得到正确发挥。 反而在个人（有钱人，就是马总）几句煽动下暴涨暴跌，这种所谓的去中心化货币与高风险的投资产品有何区别，完全不稳定也不安全。其现有价值感觉完全是依资金与名人的炒作而定的。荒谬啊
看
4,252
回复
2
点赞
12
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-12-10
Tell me your opinion about this news...
Broadcom stock jumped nearly 7% in premarket trading<blockquote>博通股价在盘前交易中上涨近 7%</blockquote>
Broadcom stock jumped nearly 7% in premarket trading as the semiconductor firm saw upbeat first-quar
Broadcom stock jumped nearly 7% in premarket trading<blockquote>博通股价在盘前交易中上涨近 7%</blockquote>
看
3,342
回复
评论
点赞
5
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-11-20
$BioHiTech Global, Inc.(BHTG)$
看不懂的走势
看
3,097
回复
评论
点赞
3
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-10
Maybe 🤔
非常抱歉，此主贴已删除
看
3,245
回复
1
点赞
5
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-09
Ok
非常抱歉，此主贴已删除
看
3,715
回复
1
点赞
5
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-08
Ok
Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children<blockquote>辉瑞要求 FDA 授权幼儿接种 Covid-19 疫苗</blockquote>
Children ages 5 to 11 may be able to start getting immunized by November if health regulators author
Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children<blockquote>辉瑞要求 FDA 授权幼儿接种 Covid-19 疫苗</blockquote>
看
3,777
回复
评论
点赞
1
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-06
Ok
非常抱歉，此主贴已删除
看
3,609
回复
2
点赞
2
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-06
Ok
非常抱歉，此主贴已删除
看
3,429
回复
评论
点赞
6
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-03
Ok
非常抱歉，此主贴已删除
看
3,924
回复
1
点赞
5
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-03
Cool
非常抱歉，此主贴已删除
看
3,004
回复
1
点赞
8
编组 21备份 2
分享
举报
不是那么好割的小韭菜
不是那么好割的小韭菜
·
2021-10-01
I use snowflake
Is Snowflake Stock A Buy? Data Analytics Specialist Rides Cloud Computing Wave<blockquote>雪花股票值得买入吗？数据分析专家乘着云计算浪潮</blockquote>
Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),M
Is Snowflake Stock A Buy? Data Analytics Specialist Rides Cloud Computing Wave<blockquote>雪花股票值得买入吗？数据分析专家乘着云计算浪潮</blockquote>
看
3,033
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3558920222538997","uuid":"3558920222538997","gmtCreate":1595826200265,"gmtModify":1614080439988,"name":"不是那么好割的小韭菜","pinyin":"bsnmhgdxjcbushinamehaogedexiaojiucai","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":32,"headSize":484,"tweetSize":353,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.25","exceedPercentage":"80.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.04%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":369423275,"gmtCreate":1614072025697,"gmtModify":1631890102966,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"对比特币真失望这几日比特币的保障暴跌让我对曾经极力看好的比特币彻底改观。比特币的优势如去中心化，匿名性，不受全球央行控制等完全没有得到正确发挥。 反而在个人（有钱人，就是马总）几句煽动下暴涨暴跌，这种所谓的去中心化货币与高风险的投资产品有何区别，完全不稳定也不安全。其现有价值感觉完全是依资金与名人的炒作而定的。荒谬啊","listText":"对比特币真失望这几日比特币的保障暴跌让我对曾经极力看好的比特币彻底改观。比特币的优势如去中心化，匿名性，不受全球央行控制等完全没有得到正确发挥。 反而在个人（有钱人，就是马总）几句煽动下暴涨暴跌，这种所谓的去中心化货币与高风险的投资产品有何区别，完全不稳定也不安全。其现有价值感觉完全是依资金与名人的炒作而定的。荒谬啊","text":"对比特币真失望这几日比特币的保障暴跌让我对曾经极力看好的比特币彻底改观。比特币的优势如去中心化，匿名性，不受全球央行控制等完全没有得到正确发挥。 反而在个人（有钱人，就是马总）几句煽动下暴涨暴跌，这种所谓的去中心化货币与高风险的投资产品有何区别，完全不稳定也不安全。其现有价值感觉完全是依资金与名人的炒作而定的。荒谬啊","images":[],"top":2,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/369423275","isVote":1,"tweetType":1,"viewCount":4252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605143095,"gmtCreate":1639134918700,"gmtModify":1639134919077,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605143095","repostId":"1191100998","repostType":2,"repost":{"id":"1191100998","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639134697,"share":"https://www.laohunote.com/m/news/1191100998?lang=zh_CN&edition=full","pubTime":"2021-12-10 19:11","market":"us","language":"en","title":"Broadcom stock jumped nearly 7% in premarket trading<blockquote>博通股价在盘前交易中上涨近 7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191100998","media":"Tiger Newspress","summary":"Broadcom stock jumped nearly 7% in premarket trading as the semiconductor firm saw upbeat first-quar","content":"<p>Broadcom stock jumped nearly 7% in premarket trading as the semiconductor firm saw upbeat first-quarter sales, unveiled $10 bln buyback plan.</p><p><blockquote>博通股价在盘前交易中上涨近 7%，这家半导体公司第一季度销售乐观，并公布了 100 亿美元的回购计划。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f168e8acd44244ccac5c7ae151b9c6be\" tg-width=\"840\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Semiconductor firm Broadcom Inc forecast first-quarter revenue above Wall Street expectations and announced a $10 billion share buyback plan on Thursday, banking on a rebound in enterprise spending and sustained demand from cloud computing companies.</p><p><blockquote>半导体公司博通公司预测第一季度收入高于华尔街预期，并于周四宣布了一项 100 亿美元的股票回购计划，指望企业支出反弹和云计算公司的持续需求。</blockquote></p><p> Analysts have pointed to strong near-term demand for Broadcom's radio frequency and wireless chips as telecom firms spend more to roll out 5G technology, and continued strength in its broadband division. The company counts smartphone giants Apple Inc and Samsung Electronics among major customers.</p><p><blockquote>分析师指出，随着电信公司投入更多资金推出 5G 技术，以及其宽带部门持续走强，近期对博通射频和无线芯片的需求强劲。该公司的主要客户包括智能手机巨头苹果公司和三星电子。</blockquote></p><p> Broadcom is also poised to benefit from higher demand for its data-center and server chips, aided by a rise in hybrid working models and a rapid shift to cloud by businesses during the pandemic.</p><p><blockquote>得益于混合工作模式的兴起以及大流行期间企业向云的快速转变，博通还将受益于对其数据中心和服务器芯片的更高需求。</blockquote></p><p> Enterprise demand rebounded sharply over 30% in the reported quarter, while revenue from semiconductor solutions is expected to grow 17% in the current quarter, Chief Executive Hock Tan said on a conference call with analysts.</p><p><blockquote>首席执行官 Hock Tan 在与分析师举行的电话会议上表示，报告季度企业需求大幅反弹超过 30%，而本季度半导体解决方案收入预计将增长 17%。</blockquote></p><p> The San Jose, California-based company forecast first-quarter revenue of about $7.60 billion, well above analysts' average estimate of $7.25 billion, according to Refinitiv data.</p><p><blockquote>根据 Refinitiv 的数据，这家总部位于加利福尼亚州圣何塞的公司预计第一季度收入约为 76.0 亿美元，远高于分析师平均预期的 72.5 亿美元。</blockquote></p><p> Fourth-quarter revenue rose 15% to $7.41 billion, narrowly beating estimates of $7.36 billion, while earnings per share of $7.81 was also better than expected.</p><p><blockquote>第四季度收入增长 15%，达到 74.1 亿美元，略高于预期的 73.6 亿美元，而每股收益 7.81 美元也好于预期。</blockquote></p><p> Broadcom has also diversified beyond its core chip business and forayed into the lucrative software arena, at a time when the world grapples with supply chain disruptions and an industry-wide chip shortage. Its infrastructure software revenue grew 8% to $1.77 billion in the fourth quarter.</p><p><blockquote>在全球努力应对供应链中断和全行业芯片短缺之际，博通还在核心芯片业务之外实现了多元化，进军利润丰厚的软件领域。第四季度其基础设施软件收入增长 8%，达到 17.7 亿美元。</blockquote></p><p> The new share repurchase program is effective until the end of next year, the company said in a separate statement.</p><p><blockquote>该公司在另一份声明中表示，新的股票回购计划有效期至明年年底。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Broadcom stock jumped nearly 7% in premarket trading<blockquote>博通股价在盘前交易中上涨近 7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBroadcom stock jumped nearly 7% in premarket trading<blockquote>博通股价在盘前交易中上涨近 7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-10 19:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Broadcom stock jumped nearly 7% in premarket trading as the semiconductor firm saw upbeat first-quarter sales, unveiled $10 bln buyback plan.</p><p><blockquote>博通股价在盘前交易中上涨近 7%，这家半导体公司第一季度销售乐观，并公布了 100 亿美元的回购计划。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f168e8acd44244ccac5c7ae151b9c6be\" tg-width=\"840\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Semiconductor firm Broadcom Inc forecast first-quarter revenue above Wall Street expectations and announced a $10 billion share buyback plan on Thursday, banking on a rebound in enterprise spending and sustained demand from cloud computing companies.</p><p><blockquote>半导体公司博通公司预测第一季度收入高于华尔街预期，并于周四宣布了一项 100 亿美元的股票回购计划，指望企业支出反弹和云计算公司的持续需求。</blockquote></p><p> Analysts have pointed to strong near-term demand for Broadcom's radio frequency and wireless chips as telecom firms spend more to roll out 5G technology, and continued strength in its broadband division. The company counts smartphone giants Apple Inc and Samsung Electronics among major customers.</p><p><blockquote>分析师指出，随着电信公司投入更多资金推出 5G 技术，以及其宽带部门持续走强，近期对博通射频和无线芯片的需求强劲。该公司的主要客户包括智能手机巨头苹果公司和三星电子。</blockquote></p><p> Broadcom is also poised to benefit from higher demand for its data-center and server chips, aided by a rise in hybrid working models and a rapid shift to cloud by businesses during the pandemic.</p><p><blockquote>得益于混合工作模式的兴起以及大流行期间企业向云的快速转变，博通还将受益于对其数据中心和服务器芯片的更高需求。</blockquote></p><p> Enterprise demand rebounded sharply over 30% in the reported quarter, while revenue from semiconductor solutions is expected to grow 17% in the current quarter, Chief Executive Hock Tan said on a conference call with analysts.</p><p><blockquote>首席执行官 Hock Tan 在与分析师举行的电话会议上表示，报告季度企业需求大幅反弹超过 30%，而本季度半导体解决方案收入预计将增长 17%。</blockquote></p><p> The San Jose, California-based company forecast first-quarter revenue of about $7.60 billion, well above analysts' average estimate of $7.25 billion, according to Refinitiv data.</p><p><blockquote>根据 Refinitiv 的数据，这家总部位于加利福尼亚州圣何塞的公司预计第一季度收入约为 76.0 亿美元，远高于分析师平均预期的 72.5 亿美元。</blockquote></p><p> Fourth-quarter revenue rose 15% to $7.41 billion, narrowly beating estimates of $7.36 billion, while earnings per share of $7.81 was also better than expected.</p><p><blockquote>第四季度收入增长 15%，达到 74.1 亿美元，略高于预期的 73.6 亿美元，而每股收益 7.81 美元也好于预期。</blockquote></p><p> Broadcom has also diversified beyond its core chip business and forayed into the lucrative software arena, at a time when the world grapples with supply chain disruptions and an industry-wide chip shortage. Its infrastructure software revenue grew 8% to $1.77 billion in the fourth quarter.</p><p><blockquote>在全球努力应对供应链中断和全行业芯片短缺之际，博通还在核心芯片业务之外实现了多元化，进军利润丰厚的软件领域。第四季度其基础设施软件收入增长 8%，达到 17.7 亿美元。</blockquote></p><p> The new share repurchase program is effective until the end of next year, the company said in a separate statement.</p><p><blockquote>该公司在另一份声明中表示，新的股票回购计划有效期至明年年底。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVGO":"博通"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191100998","content_text":"Broadcom stock jumped nearly 7% in premarket trading as the semiconductor firm saw upbeat first-quarter sales, unveiled $10 bln buyback plan.\n\nSemiconductor firm Broadcom Inc forecast first-quarter revenue above Wall Street expectations and announced a $10 billion share buyback plan on Thursday, banking on a rebound in enterprise spending and sustained demand from cloud computing companies.\nAnalysts have pointed to strong near-term demand for Broadcom's radio frequency and wireless chips as telecom firms spend more to roll out 5G technology, and continued strength in its broadband division. The company counts smartphone giants Apple Inc and Samsung Electronics among major customers.\nBroadcom is also poised to benefit from higher demand for its data-center and server chips, aided by a rise in hybrid working models and a rapid shift to cloud by businesses during the pandemic.\nEnterprise demand rebounded sharply over 30% in the reported quarter, while revenue from semiconductor solutions is expected to grow 17% in the current quarter, Chief Executive Hock Tan said on a conference call with analysts.\nThe San Jose, California-based company forecast first-quarter revenue of about $7.60 billion, well above analysts' average estimate of $7.25 billion, according to Refinitiv data.\nFourth-quarter revenue rose 15% to $7.41 billion, narrowly beating estimates of $7.36 billion, while earnings per share of $7.81 was also better than expected.\nBroadcom has also diversified beyond its core chip business and forayed into the lucrative software arena, at a time when the world grapples with supply chain disruptions and an industry-wide chip shortage. Its infrastructure software revenue grew 8% to $1.77 billion in the fourth quarter.\nThe new share repurchase program is effective until the end of next year, the company said in a separate statement.","news_type":1,"symbols_score_info":{"AVGO":0.9}},"isVote":1,"tweetType":1,"viewCount":3342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872997629,"gmtCreate":1637386202256,"gmtModify":1637386202869,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BHTG\">$BioHiTech Global, Inc.(BHTG)$</a>看不懂的走势","listText":"<a href=\"https://laohu8.com/S/BHTG\">$BioHiTech Global, Inc.(BHTG)$</a>看不懂的走势","text":"$BioHiTech Global, Inc.(BHTG)$看不懂的走势","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872997629","isVote":1,"tweetType":1,"viewCount":3097,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828112491,"gmtCreate":1633863737094,"gmtModify":1633863737899,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Maybe 🤔 ","listText":"Maybe 🤔 ","text":"Maybe 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828112491","repostId":"1194780749","repostType":4,"isVote":1,"tweetType":1,"viewCount":3245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821428395,"gmtCreate":1633776469516,"gmtModify":1633776469743,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/821428395","repostId":"1167388174","repostType":4,"isVote":1,"tweetType":1,"viewCount":3715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823557997,"gmtCreate":1633651089331,"gmtModify":1633651089982,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823557997","repostId":"1152262514","repostType":4,"repost":{"id":"1152262514","kind":"news","pubTimestamp":1633649428,"share":"https://www.laohunote.com/m/news/1152262514?lang=zh_CN&edition=full","pubTime":"2021-10-08 07:30","market":"us","language":"en","title":"Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children<blockquote>辉瑞要求 FDA 授权幼儿接种 Covid-19 疫苗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152262514","media":"The Wall Street Journal","summary":"Children ages 5 to 11 may be able to start getting immunized by November if health regulators author","content":"<p>Children ages 5 to 11 may be able to start getting immunized by November if health regulators authorize the shots</p><p><blockquote>如果卫生监管机构批准注射，5 至 11 岁的儿童可能能够在 11 月之前开始接种疫苗</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/67355adb6edb0e8646555bf98ce5a2a3\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>A team at a pharmacy in Ohio in August prepared the Pfizer vaccine as part of a trial in children under the age of 12.</span></p><p><blockquote><p class=\"t-img-caption\"><span>8 月份，俄亥俄州一家药房的一个团队准备了辉瑞疫苗，作为 12 岁以下儿童试验的一部分。</span></p></blockquote></p><p> Pfizer Inc. and BioNTech SE have asked U.S. health regulators to green light their Covid-19 vaccine for children 5 to 11 years old, setting up the shot to potentially be available to millions of youngsters in a matter of weeks.</p><p><blockquote>辉瑞公司 (Pfizer Inc.) 和 BioNTech SE 已要求美国卫生监管机构为 5 至 11 岁儿童接种 Covid-19 疫苗开绿灯，预计数百万年轻人可能会在几周内接种该疫苗。</blockquote></p><p> The companies said Thursday that they submitted the application for authorization with the U.S. Food and Drug Administration.</p><p><blockquote>两家公司周四表示，他们已向美国提交了授权申请。食品药品监督管理局。</blockquote></p><p> The FDA may clear the shot for use in the youths before November, which would mean pediatrician offices, schools and other locations could get doses to give as early as Halloween.</p><p><blockquote>美国食品和药物管理局可能会在11月之前批准在年轻人中使用这种疫苗，这意味着儿科医生办公室、学校和其他地方最早可以在万圣节获得剂量。</blockquote></p><p> There are more than 28 million children ages 5 to 11 in the U.S., according to the American Academy of Pediatrics.</p><p><blockquote>根据美国儿科学会的数据，美国有超过2800万5至11岁的儿童。</blockquote></p><p> The FDA has already scheduled for a panel of outside experts to review the data Oct. 26. The agency doesn’t have to follow the panel’s recommendation, but normally does.</p><p><blockquote>FDA 已安排外部专家小组于 10 月 26 日审查这些数据。该机构不必遵循小组的建议，但通常会遵循。</blockquote></p><p> If authorized, young children would get two injections of the Pfizer-BioNTech, three weeks apart, just like adolescents and adults do but at a lower dosage.</p><p><blockquote>如果获得授权，幼儿将像青少年和成年人一样，间隔三周注射两次辉瑞-BioNTech，但剂量较低。</blockquote></p><p> School districts and public-health officials have begun preparations for vaccinations, though the work remains in early stages. Health and vaccine experts expect the vaccines to be administered at certain schools, pediatrician offices and some pharmacies.</p><p><blockquote>学区和公共卫生官员已经开始准备接种疫苗，尽管这项工作仍处于早期阶段。健康和疫苗专家预计疫苗将在某些学校、儿科医生办公室和一些药店接种。</blockquote></p><p> Schools and public-health departments are experienced with childhood vaccines unrelated to Covid-19 because they routinely administer them, although the cold-storage requirements of the Pfizer-BioNTech vaccine may pose some challenges, according to the experts.</p><p><blockquote>专家表示，学校和公共卫生部门在与新冠肺炎无关的儿童疫苗方面经验丰富，因为他们经常接种这些疫苗，尽管辉瑞-BioNTech疫苗的冷藏要求可能会带来一些挑战。</blockquote></p><p> Pediatrician offices and other administration sites won’t be able to vaccinate the children with existing supply on hand because doses for children are smaller and prepared differently than for adults. Pfizer said it would start shipping the pediatric doses, if authorized, as soon as it is cleared to do so by U.S. health authorities.</p><p><blockquote>儿科医生办公室和其他管理点将无法用现有的疫苗为儿童接种疫苗，因为儿童的疫苗剂量较小，而且准备方式与成人不同。辉瑞公司表示，如果获得授权，一旦获得美国卫生当局的批准，它将立即开始运输儿科剂量。</blockquote></p><p> The filing comes after the vaccine appeared to safely generate a strong immune response in young subjects in a late-stage trial, according to the companies.</p><p><blockquote>据两家公司称，该疫苗似乎在后期试验中安全地在年轻受试者中产生了强烈的免疫反应。</blockquote></p><p> Antibody levels in the child volunteers who received the vaccine were similar to those observed in younger adults, the companies said.</p><p><blockquote>两家公司表示，接种疫苗的儿童志愿者的抗体水平与年轻人的抗体水平相似。</blockquote></p><p> The FDA has already been reviewing the Pfizer-BioNTech study data, after the companies began providing it to the agency in September. The companies still needed to submit other information, however, and the adjusted timeline could stretch authorization into November,The Wall Street Journal has reported.</p><p><blockquote>在辉瑞-BioNTech公司于9月份开始向该机构提供该研究数据后，FDA已经在审查辉瑞-BioNTech公司的研究数据。然而，据《华尔街日报》报道，这些公司仍需提交其他信息，调整后的时间表可能会将授权延长至 11 月。</blockquote></p><p> Young children are among the last groups in the U.S. waiting for vaccines against the coronavirus authorized by the FDA.</p><p><blockquote>幼儿是美国最后一批等待 FDA 批准的冠状病毒疫苗的群体之一。</blockquote></p><p> They are at lower risk of severe disease and hospitalization than adults, according to health experts, but more children have been going to the hospital than earlier in the pandemic because of the highly contagious Delta variant’s spread primarily among unvaccinated people.</p><p><blockquote>卫生专家表示，与成年人相比，他们患重病和住院的风险较低，但由于高传染性德尔塔变异毒株病毒主要在未接种疫苗的人群中传播，因此前往医院就诊的儿童人数比大流行早期要多。</blockquote></p><p> Many parents have been anxious to get their young children vaccinated, hoping to protect them as the school year gets under way.</p><p><blockquote>许多父母一直急于让他们的孩子接种疫苗，希望在新学年开始时保护他们。</blockquote></p><p> Some parents with younger children have been so eager to get their young children vaccinated they enrolled them in clinical trials hoping the youngsters would get the real shots, rather than a placebo.</p><p><blockquote>一些有年幼孩子的父母非常渴望让他们的年幼孩子接种疫苗，他们让他们参加临床试验，希望年轻人能接种真正的疫苗，而不是安慰剂。</blockquote></p><p> Doctors and health authorities have said it will be important to immunize the children, not only to protect them from the virus but also to help protect children around them and family members.</p><p><blockquote>医生和卫生当局表示，给儿童接种疫苗非常重要，这不仅是为了保护他们免受病毒的侵害，也是为了帮助保护他们周围的儿童和家庭成员。</blockquote></p><p> Pediatricians and public health experts say that much work will need to be done to address parents’ concerns about vaccinating young children, including parents who received Covid-19 vaccines themselves.</p><p><blockquote>儿科医生和公共卫生专家表示，需要做大量工作来解决家长对给幼儿接种疫苗的担忧，包括那些自己接种了 Covid-19 疫苗的家长。</blockquote></p><p> About one-third of parents of children 5 to 11 years old plan to “wait and see” how the shot performs before vaccinating their children, while about one-quarter of parents said they had no plans to inoculate their children, according to a survey published in September by the Kaiser Family Foundation.</p><p><blockquote>凯撒家庭基金会（Kaiser Family Foundation）9 月份公布的一项调查显示，约三分之一有 5 至 11 岁儿童的家长计划在给孩子接种疫苗之前 “观望 ”疫苗的效果，而约四分之一的家长表示他们没有给孩子接种疫苗的计划。</blockquote></p><p> About 34% of parents of children ages 5 to 11 years would vaccinate their children right away after regulators clear vaccines for that age group, according to the survey.</p><p><blockquote>调查显示，在监管机构批准针对 5 至 11 岁儿童的疫苗后，约 34% 的 5 至 11 岁儿童的父母会立即为孩子接种疫苗。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6cbf9d4fb7f80be2243e6f18a234ee9\" tg-width=\"1050\" tg-height=\"701\" width=\"100%\" height=\"auto\"><span>A vaccination clinic in Carson, Calif.</span></p><p><blockquote><p class=\"t-img-caption\"><span>加州卡森的一家疫苗接种诊所。</span></p></blockquote></p><p> After the authorization in 5- to 11-year-olds, the only group left awaiting vaccines will be children as young as six months.</p><p><blockquote>在5至11岁儿童获得授权后，唯一等待疫苗的群体将是6个月大的儿童。</blockquote></p><p></p><p> Pfizer has said that results from a study in the younger children, ages 6 months to under 5 years, could come by the fourth quarter this year.</p><p><blockquote>辉瑞公司表示，一项针对 6 个月至 5 岁以下儿童的研究结果可能会在今年第四季度得出。</blockquote></p><p> For 5- to 11-year-olds, the companies are seeking what is known as an emergency-use authorization, which the FDA grants during public-health emergencies based on the best available evidence at the time.</p><p><blockquote>对于 5 至 11 岁的儿童，这些公司正在寻求所谓的紧急使用授权，FDA 根据当时现有的最佳证据在公共卫生紧急情况下授予该授权。</blockquote></p><p> To speed the availability of Covid-19 vaccines because of the urgency of the pandemic, the FDA has been authorizing shots including Pfizer-BioNTech’s for emergency use.</p><p><blockquote>由于大流行病的紧迫性，为了加快 Covid-19 疫苗的供应，美国食品和药物管理局一直在授权包括辉瑞-BioNTech 疫苗在内的疫苗用于紧急使用。</blockquote></p><p> Children as young as 12 are permitted to take the Pfizer-BioNTech shot under an emergency-use authorization. The vaccine is now fully approved for people 16 years and older.</p><p><blockquote>根据紧急使用授权，12岁的儿童可以注射辉瑞-BioNTech疫苗。该疫苗现已完全批准用于16岁及以上的人群。</blockquote></p><p> In their key study, Pfizer and BioNTech enrolled about 2,268 subjects 5 to 11 years. Two-thirds of the subjects got two doses of the vaccine, three weeks apart, with the rest getting a placebo. Children received a smaller, 10 microgram dosage, compared with the 30 microgram dose than adults take.</p><p><blockquote>在他们的关键研究中，辉瑞和BioNTech招募了大约2268名5至11岁的受试者。三分之二的受试者间隔三周接种两剂疫苗，其余受试者接种安慰剂。与成人服用的30微克剂量相比，儿童接受的10微克剂量较小。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6b596ccbc070386938764cd6817f695f\" tg-width=\"1050\" tg-height=\"700\" width=\"100%\" height=\"auto\"><span>A health-care worker met with a volunteer in Ohio in August as part of a vaccine trial for children under 12.</span></p><p><blockquote><p class=\"t-img-caption\"><span>8 月，一名卫生保健工作者在俄亥俄州会见了一名志愿者，作为针对 12 岁以下儿童的疫苗试验的一部分。</span></p></blockquote></p><p> Pfizer hasn’t provided detailed results yet but did say an analysis of data of children taking the vaccine had neutralizing antibody levels one month after the second dose similar to those found in people ages 16 to 25 years who received 30-microgram doses in a separate Pfizer study.</p><p><blockquote>辉瑞公司尚未提供详细结果，但确实表示，对接种疫苗的儿童的数据分析显示，第二剂疫苗一个月后的中和抗体水平与辉瑞公司在另一项研究中发现的 16 至 25 岁接种 30 微克剂量疫苗的人群相似。</blockquote></p><p> Neutralizing antibodies, which prevent the virus from entering cells and replicating, play a key role in the body’s immune response against Covid-19.</p><p><blockquote>中和抗体可以阻止病毒进入细胞和复制，在人体对 Covid-19 的免疫反应中起着关键作用。</blockquote></p><p> The companies haven’t been able to say yet how well the shot protects against Covid-19 because too few young subjects in the study have become sick to compare rates between children who got a vaccine and those who got a placebo.</p><p><blockquote>由于研究中患病的年轻受试者太少，无法比较接种疫苗和接种安慰剂的儿童之间的发病率，因此两家公司还不能透露这种疫苗对 Covid-19 的保护效果如何。</blockquote></p><p> Yet the FDA commonly clears vaccines based on data indicating a vaccine already shown to be protective in older people generates similar antibody levels in young children as in adults.</p><p><blockquote>然而，FDA 通常会根据数据批准疫苗，这些数据表明已经被证明对老年人具有保护作用的疫苗在幼儿中产生的抗体水平与成人相似。</blockquote></p><p> There appeared to be fewer side effects such as fever and chills among younger children who got the vaccine compared with 16- to 25-year-olds, Pfizer has said.</p><p><blockquote>辉瑞公司表示，与 16 至 25 岁的儿童相比，接种疫苗的年龄较小的儿童出现发烧和发冷等副作用似乎较少。</blockquote></p><p> There also were no cases of myocarditis, an inflammatory heart condition that has so far been found to be a rare side effect primarily in young men, Pfizer said.</p><p><blockquote>辉瑞公司表示，也没有心肌炎病例，心肌炎是一种炎症性心脏病，迄今为止被发现是一种罕见的副作用，主要发生在年轻男性身上。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children<blockquote>辉瑞要求 FDA 授权幼儿接种 Covid-19 疫苗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children<blockquote>辉瑞要求 FDA 授权幼儿接种 Covid-19 疫苗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-10-08 07:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Children ages 5 to 11 may be able to start getting immunized by November if health regulators authorize the shots</p><p><blockquote>如果卫生监管机构批准注射，5 至 11 岁的儿童可能能够在 11 月之前开始接种疫苗</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/67355adb6edb0e8646555bf98ce5a2a3\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>A team at a pharmacy in Ohio in August prepared the Pfizer vaccine as part of a trial in children under the age of 12.</span></p><p><blockquote><p class=\"t-img-caption\"><span>8 月份，俄亥俄州一家药房的一个团队准备了辉瑞疫苗，作为 12 岁以下儿童试验的一部分。</span></p></blockquote></p><p> Pfizer Inc. and BioNTech SE have asked U.S. health regulators to green light their Covid-19 vaccine for children 5 to 11 years old, setting up the shot to potentially be available to millions of youngsters in a matter of weeks.</p><p><blockquote>辉瑞公司 (Pfizer Inc.) 和 BioNTech SE 已要求美国卫生监管机构为 5 至 11 岁儿童接种 Covid-19 疫苗开绿灯，预计数百万年轻人可能会在几周内接种该疫苗。</blockquote></p><p> The companies said Thursday that they submitted the application for authorization with the U.S. Food and Drug Administration.</p><p><blockquote>两家公司周四表示，他们已向美国提交了授权申请。食品药品监督管理局。</blockquote></p><p> The FDA may clear the shot for use in the youths before November, which would mean pediatrician offices, schools and other locations could get doses to give as early as Halloween.</p><p><blockquote>美国食品和药物管理局可能会在11月之前批准在年轻人中使用这种疫苗，这意味着儿科医生办公室、学校和其他地方最早可以在万圣节获得剂量。</blockquote></p><p> There are more than 28 million children ages 5 to 11 in the U.S., according to the American Academy of Pediatrics.</p><p><blockquote>根据美国儿科学会的数据，美国有超过2800万5至11岁的儿童。</blockquote></p><p> The FDA has already scheduled for a panel of outside experts to review the data Oct. 26. The agency doesn’t have to follow the panel’s recommendation, but normally does.</p><p><blockquote>FDA 已安排外部专家小组于 10 月 26 日审查这些数据。该机构不必遵循小组的建议，但通常会遵循。</blockquote></p><p> If authorized, young children would get two injections of the Pfizer-BioNTech, three weeks apart, just like adolescents and adults do but at a lower dosage.</p><p><blockquote>如果获得授权，幼儿将像青少年和成年人一样，间隔三周注射两次辉瑞-BioNTech，但剂量较低。</blockquote></p><p> School districts and public-health officials have begun preparations for vaccinations, though the work remains in early stages. Health and vaccine experts expect the vaccines to be administered at certain schools, pediatrician offices and some pharmacies.</p><p><blockquote>学区和公共卫生官员已经开始准备接种疫苗，尽管这项工作仍处于早期阶段。健康和疫苗专家预计疫苗将在某些学校、儿科医生办公室和一些药店接种。</blockquote></p><p> Schools and public-health departments are experienced with childhood vaccines unrelated to Covid-19 because they routinely administer them, although the cold-storage requirements of the Pfizer-BioNTech vaccine may pose some challenges, according to the experts.</p><p><blockquote>专家表示，学校和公共卫生部门在与新冠肺炎无关的儿童疫苗方面经验丰富，因为他们经常接种这些疫苗，尽管辉瑞-BioNTech疫苗的冷藏要求可能会带来一些挑战。</blockquote></p><p> Pediatrician offices and other administration sites won’t be able to vaccinate the children with existing supply on hand because doses for children are smaller and prepared differently than for adults. Pfizer said it would start shipping the pediatric doses, if authorized, as soon as it is cleared to do so by U.S. health authorities.</p><p><blockquote>儿科医生办公室和其他管理点将无法用现有的疫苗为儿童接种疫苗，因为儿童的疫苗剂量较小，而且准备方式与成人不同。辉瑞公司表示，如果获得授权，一旦获得美国卫生当局的批准，它将立即开始运输儿科剂量。</blockquote></p><p> The filing comes after the vaccine appeared to safely generate a strong immune response in young subjects in a late-stage trial, according to the companies.</p><p><blockquote>据两家公司称，该疫苗似乎在后期试验中安全地在年轻受试者中产生了强烈的免疫反应。</blockquote></p><p> Antibody levels in the child volunteers who received the vaccine were similar to those observed in younger adults, the companies said.</p><p><blockquote>两家公司表示，接种疫苗的儿童志愿者的抗体水平与年轻人的抗体水平相似。</blockquote></p><p> The FDA has already been reviewing the Pfizer-BioNTech study data, after the companies began providing it to the agency in September. The companies still needed to submit other information, however, and the adjusted timeline could stretch authorization into November,The Wall Street Journal has reported.</p><p><blockquote>在辉瑞-BioNTech公司于9月份开始向该机构提供该研究数据后，FDA已经在审查辉瑞-BioNTech公司的研究数据。然而，据《华尔街日报》报道，这些公司仍需提交其他信息，调整后的时间表可能会将授权延长至 11 月。</blockquote></p><p> Young children are among the last groups in the U.S. waiting for vaccines against the coronavirus authorized by the FDA.</p><p><blockquote>幼儿是美国最后一批等待 FDA 批准的冠状病毒疫苗的群体之一。</blockquote></p><p> They are at lower risk of severe disease and hospitalization than adults, according to health experts, but more children have been going to the hospital than earlier in the pandemic because of the highly contagious Delta variant’s spread primarily among unvaccinated people.</p><p><blockquote>卫生专家表示，与成年人相比，他们患重病和住院的风险较低，但由于高传染性德尔塔变异毒株病毒主要在未接种疫苗的人群中传播，因此前往医院就诊的儿童人数比大流行早期要多。</blockquote></p><p> Many parents have been anxious to get their young children vaccinated, hoping to protect them as the school year gets under way.</p><p><blockquote>许多父母一直急于让他们的孩子接种疫苗，希望在新学年开始时保护他们。</blockquote></p><p> Some parents with younger children have been so eager to get their young children vaccinated they enrolled them in clinical trials hoping the youngsters would get the real shots, rather than a placebo.</p><p><blockquote>一些有年幼孩子的父母非常渴望让他们的年幼孩子接种疫苗，他们让他们参加临床试验，希望年轻人能接种真正的疫苗，而不是安慰剂。</blockquote></p><p> Doctors and health authorities have said it will be important to immunize the children, not only to protect them from the virus but also to help protect children around them and family members.</p><p><blockquote>医生和卫生当局表示，给儿童接种疫苗非常重要，这不仅是为了保护他们免受病毒的侵害，也是为了帮助保护他们周围的儿童和家庭成员。</blockquote></p><p> Pediatricians and public health experts say that much work will need to be done to address parents’ concerns about vaccinating young children, including parents who received Covid-19 vaccines themselves.</p><p><blockquote>儿科医生和公共卫生专家表示，需要做大量工作来解决家长对给幼儿接种疫苗的担忧，包括那些自己接种了 Covid-19 疫苗的家长。</blockquote></p><p> About one-third of parents of children 5 to 11 years old plan to “wait and see” how the shot performs before vaccinating their children, while about one-quarter of parents said they had no plans to inoculate their children, according to a survey published in September by the Kaiser Family Foundation.</p><p><blockquote>凯撒家庭基金会（Kaiser Family Foundation）9 月份公布的一项调查显示，约三分之一有 5 至 11 岁儿童的家长计划在给孩子接种疫苗之前 “观望 ”疫苗的效果，而约四分之一的家长表示他们没有给孩子接种疫苗的计划。</blockquote></p><p> About 34% of parents of children ages 5 to 11 years would vaccinate their children right away after regulators clear vaccines for that age group, according to the survey.</p><p><blockquote>调查显示，在监管机构批准针对 5 至 11 岁儿童的疫苗后，约 34% 的 5 至 11 岁儿童的父母会立即为孩子接种疫苗。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6cbf9d4fb7f80be2243e6f18a234ee9\" tg-width=\"1050\" tg-height=\"701\" width=\"100%\" height=\"auto\"><span>A vaccination clinic in Carson, Calif.</span></p><p><blockquote><p class=\"t-img-caption\"><span>加州卡森的一家疫苗接种诊所。</span></p></blockquote></p><p> After the authorization in 5- to 11-year-olds, the only group left awaiting vaccines will be children as young as six months.</p><p><blockquote>在5至11岁儿童获得授权后，唯一等待疫苗的群体将是6个月大的儿童。</blockquote></p><p></p><p> Pfizer has said that results from a study in the younger children, ages 6 months to under 5 years, could come by the fourth quarter this year.</p><p><blockquote>辉瑞公司表示，一项针对 6 个月至 5 岁以下儿童的研究结果可能会在今年第四季度得出。</blockquote></p><p> For 5- to 11-year-olds, the companies are seeking what is known as an emergency-use authorization, which the FDA grants during public-health emergencies based on the best available evidence at the time.</p><p><blockquote>对于 5 至 11 岁的儿童，这些公司正在寻求所谓的紧急使用授权，FDA 根据当时现有的最佳证据在公共卫生紧急情况下授予该授权。</blockquote></p><p> To speed the availability of Covid-19 vaccines because of the urgency of the pandemic, the FDA has been authorizing shots including Pfizer-BioNTech’s for emergency use.</p><p><blockquote>由于大流行病的紧迫性，为了加快 Covid-19 疫苗的供应，美国食品和药物管理局一直在授权包括辉瑞-BioNTech 疫苗在内的疫苗用于紧急使用。</blockquote></p><p> Children as young as 12 are permitted to take the Pfizer-BioNTech shot under an emergency-use authorization. The vaccine is now fully approved for people 16 years and older.</p><p><blockquote>根据紧急使用授权，12岁的儿童可以注射辉瑞-BioNTech疫苗。该疫苗现已完全批准用于16岁及以上的人群。</blockquote></p><p> In their key study, Pfizer and BioNTech enrolled about 2,268 subjects 5 to 11 years. Two-thirds of the subjects got two doses of the vaccine, three weeks apart, with the rest getting a placebo. Children received a smaller, 10 microgram dosage, compared with the 30 microgram dose than adults take.</p><p><blockquote>在他们的关键研究中，辉瑞和BioNTech招募了大约2268名5至11岁的受试者。三分之二的受试者间隔三周接种两剂疫苗，其余受试者接种安慰剂。与成人服用的30微克剂量相比，儿童接受的10微克剂量较小。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6b596ccbc070386938764cd6817f695f\" tg-width=\"1050\" tg-height=\"700\" width=\"100%\" height=\"auto\"><span>A health-care worker met with a volunteer in Ohio in August as part of a vaccine trial for children under 12.</span></p><p><blockquote><p class=\"t-img-caption\"><span>8 月，一名卫生保健工作者在俄亥俄州会见了一名志愿者，作为针对 12 岁以下儿童的疫苗试验的一部分。</span></p></blockquote></p><p> Pfizer hasn’t provided detailed results yet but did say an analysis of data of children taking the vaccine had neutralizing antibody levels one month after the second dose similar to those found in people ages 16 to 25 years who received 30-microgram doses in a separate Pfizer study.</p><p><blockquote>辉瑞公司尚未提供详细结果，但确实表示，对接种疫苗的儿童的数据分析显示，第二剂疫苗一个月后的中和抗体水平与辉瑞公司在另一项研究中发现的 16 至 25 岁接种 30 微克剂量疫苗的人群相似。</blockquote></p><p> Neutralizing antibodies, which prevent the virus from entering cells and replicating, play a key role in the body’s immune response against Covid-19.</p><p><blockquote>中和抗体可以阻止病毒进入细胞和复制，在人体对 Covid-19 的免疫反应中起着关键作用。</blockquote></p><p> The companies haven’t been able to say yet how well the shot protects against Covid-19 because too few young subjects in the study have become sick to compare rates between children who got a vaccine and those who got a placebo.</p><p><blockquote>由于研究中患病的年轻受试者太少，无法比较接种疫苗和接种安慰剂的儿童之间的发病率，因此两家公司还不能透露这种疫苗对 Covid-19 的保护效果如何。</blockquote></p><p> Yet the FDA commonly clears vaccines based on data indicating a vaccine already shown to be protective in older people generates similar antibody levels in young children as in adults.</p><p><blockquote>然而，FDA 通常会根据数据批准疫苗，这些数据表明已经被证明对老年人具有保护作用的疫苗在幼儿中产生的抗体水平与成人相似。</blockquote></p><p> There appeared to be fewer side effects such as fever and chills among younger children who got the vaccine compared with 16- to 25-year-olds, Pfizer has said.</p><p><blockquote>辉瑞公司表示，与 16 至 25 岁的儿童相比，接种疫苗的年龄较小的儿童出现发烧和发冷等副作用似乎较少。</blockquote></p><p> There also were no cases of myocarditis, an inflammatory heart condition that has so far been found to be a rare side effect primarily in young men, Pfizer said.</p><p><blockquote>辉瑞公司表示，也没有心肌炎病例，心肌炎是一种炎症性心脏病，迄今为止被发现是一种罕见的副作用，主要发生在年轻男性身上。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-asks-fda-to-approve-covid-19-vaccine-in-young-children-11633610319?mod=hp_lead_pos7\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.wsj.com/articles/pfizer-asks-fda-to-approve-covid-19-vaccine-in-young-children-11633610319?mod=hp_lead_pos7","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152262514","content_text":"Children ages 5 to 11 may be able to start getting immunized by November if health regulators authorize the shots\nA team at a pharmacy in Ohio in August prepared the Pfizer vaccine as part of a trial in children under the age of 12.\nPfizer Inc. and BioNTech SE have asked U.S. health regulators to green light their Covid-19 vaccine for children 5 to 11 years old, setting up the shot to potentially be available to millions of youngsters in a matter of weeks.\nThe companies said Thursday that they submitted the application for authorization with the U.S. Food and Drug Administration.\nThe FDA may clear the shot for use in the youths before November, which would mean pediatrician offices, schools and other locations could get doses to give as early as Halloween.\nThere are more than 28 million children ages 5 to 11 in the U.S., according to the American Academy of Pediatrics.\nThe FDA has already scheduled for a panel of outside experts to review the data Oct. 26. The agency doesn’t have to follow the panel’s recommendation, but normally does.\nIf authorized, young children would get two injections of the Pfizer-BioNTech, three weeks apart, just like adolescents and adults do but at a lower dosage.\nSchool districts and public-health officials have begun preparations for vaccinations, though the work remains in early stages. Health and vaccine experts expect the vaccines to be administered at certain schools, pediatrician offices and some pharmacies.\nSchools and public-health departments are experienced with childhood vaccines unrelated to Covid-19 because they routinely administer them, although the cold-storage requirements of the Pfizer-BioNTech vaccine may pose some challenges, according to the experts.\nPediatrician offices and other administration sites won’t be able to vaccinate the children with existing supply on hand because doses for children are smaller and prepared differently than for adults. Pfizer said it would start shipping the pediatric doses, if authorized, as soon as it is cleared to do so by U.S. health authorities.\nThe filing comes after the vaccine appeared to safely generate a strong immune response in young subjects in a late-stage trial, according to the companies.\nAntibody levels in the child volunteers who received the vaccine were similar to those observed in younger adults, the companies said.\nThe FDA has already been reviewing the Pfizer-BioNTech study data, after the companies began providing it to the agency in September. The companies still needed to submit other information, however, and the adjusted timeline could stretch authorization into November,The Wall Street Journal has reported.\nYoung children are among the last groups in the U.S. waiting for vaccines against the coronavirus authorized by the FDA.\nThey are at lower risk of severe disease and hospitalization than adults, according to health experts, but more children have been going to the hospital than earlier in the pandemic because of the highly contagious Delta variant’s spread primarily among unvaccinated people.\nMany parents have been anxious to get their young children vaccinated, hoping to protect them as the school year gets under way.\nSome parents with younger children have been so eager to get their young children vaccinated they enrolled them in clinical trials hoping the youngsters would get the real shots, rather than a placebo.\nDoctors and health authorities have said it will be important to immunize the children, not only to protect them from the virus but also to help protect children around them and family members.\nPediatricians and public health experts say that much work will need to be done to address parents’ concerns about vaccinating young children, including parents who received Covid-19 vaccines themselves.\nAbout one-third of parents of children 5 to 11 years old plan to “wait and see” how the shot performs before vaccinating their children, while about one-quarter of parents said they had no plans to inoculate their children, according to a survey published in September by the Kaiser Family Foundation.\nAbout 34% of parents of children ages 5 to 11 years would vaccinate their children right away after regulators clear vaccines for that age group, according to the survey.\nA vaccination clinic in Carson, Calif.\nAfter the authorization in 5- to 11-year-olds, the only group left awaiting vaccines will be children as young as six months.\nPfizer has said that results from a study in the younger children, ages 6 months to under 5 years, could come by the fourth quarter this year.\nFor 5- to 11-year-olds, the companies are seeking what is known as an emergency-use authorization, which the FDA grants during public-health emergencies based on the best available evidence at the time.\nTo speed the availability of Covid-19 vaccines because of the urgency of the pandemic, the FDA has been authorizing shots including Pfizer-BioNTech’s for emergency use.\nChildren as young as 12 are permitted to take the Pfizer-BioNTech shot under an emergency-use authorization. The vaccine is now fully approved for people 16 years and older.\nIn their key study, Pfizer and BioNTech enrolled about 2,268 subjects 5 to 11 years. Two-thirds of the subjects got two doses of the vaccine, three weeks apart, with the rest getting a placebo. Children received a smaller, 10 microgram dosage, compared with the 30 microgram dose than adults take.\nA health-care worker met with a volunteer in Ohio in August as part of a vaccine trial for children under 12.\nPfizer hasn’t provided detailed results yet but did say an analysis of data of children taking the vaccine had neutralizing antibody levels one month after the second dose similar to those found in people ages 16 to 25 years who received 30-microgram doses in a separate Pfizer study.\nNeutralizing antibodies, which prevent the virus from entering cells and replicating, play a key role in the body’s immune response against Covid-19.\nThe companies haven’t been able to say yet how well the shot protects against Covid-19 because too few young subjects in the study have become sick to compare rates between children who got a vaccine and those who got a placebo.\nYet the FDA commonly clears vaccines based on data indicating a vaccine already shown to be protective in older people generates similar antibody levels in young children as in adults.\nThere appeared to be fewer side effects such as fever and chills among younger children who got the vaccine compared with 16- to 25-year-olds, Pfizer has said.\nThere also were no cases of myocarditis, an inflammatory heart condition that has so far been found to be a rare side effect primarily in young men, Pfizer said.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3777,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829594383,"gmtCreate":1633524881842,"gmtModify":1633524882510,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829594383","repostId":"2173917928","repostType":4,"isVote":1,"tweetType":1,"viewCount":3609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829592256,"gmtCreate":1633524789743,"gmtModify":1633524790395,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829592256","repostId":"1126487365","repostType":4,"isVote":1,"tweetType":1,"viewCount":3429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867662959,"gmtCreate":1633255480907,"gmtModify":1633255481480,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867662959","repostId":"2172614079","repostType":4,"isVote":1,"tweetType":1,"viewCount":3924,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867666684,"gmtCreate":1633255399843,"gmtModify":1633255400497,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867666684","repostId":"2172647479","repostType":4,"isVote":1,"tweetType":1,"viewCount":3004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864320633,"gmtCreate":1633059523584,"gmtModify":1633059524197,"author":{"id":"3558920222538997","authorId":"3558920222538997","name":"不是那么好割的小韭菜","avatar":"https://static.tigerbbs.com/904e087829710bbff7692246e238149c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3558920222538997","idStr":"3558920222538997"},"themes":[],"title":"","htmlText":"I use snowflake ","listText":"I use snowflake ","text":"I use snowflake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864320633","repostId":"1155834484","repostType":4,"repost":{"id":"1155834484","kind":"news","pubTimestamp":1633047614,"share":"https://www.laohunote.com/m/news/1155834484?lang=zh_CN&edition=full","pubTime":"2021-10-01 08:20","market":"us","language":"en","title":"Is Snowflake Stock A Buy? Data Analytics Specialist Rides Cloud Computing Wave<blockquote>雪花股票值得买入吗？数据分析专家乘着云计算浪潮</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1155834484","media":"investors","summary":"Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),M","content":"<p>Think of Snowflake stock as a proxy on the torrid growth of cloud computing giants<b>Amazon.com</b>(AMZN),<b>Microsoft</b>(MSFT) and<b>Alphabet</b>'s (GOOGL) Google.</p><p><blockquote>将雪花股票视为云计算巨头快速增长的代表<b>亚马逊</b>（亚马逊），<b>微软</b>（MSFT）和<b>Alphabet</b>（GOOGL）谷歌。</blockquote></p><p> Many companies are turning to cloud computing services as part of \"digital transformation\" projects that aim to gain business insights from crunching massive volumes of data. The cloud computing titans offer their own data analytics and management tools.</p><p><blockquote>许多公司正在转向云计算服务，作为“数字化转型”项目的一部分，这些项目旨在从处理大量数据中获得业务洞察力。云计算巨头提供自己的数据分析和管理工具。</blockquote></p><p> In a \"coopetition\" model, thecloud giantsgive their customers a green light to buy<b>Snowflake</b>'s (SNOW) software. The reason is Snowflake's tools are better at some key tasks, such as letting companies compile, view, analyze and share massive amounts of data in an easy way.</p><p><blockquote>在“合作竞争”模式下，云巨头为客户购买开绿灯<b>雪花</b>的（雪）软件。原因是Snowflake的工具在一些关键任务上表现更好，比如让公司以简单的方式编译、查看、分析和共享海量数据。</blockquote></p><p> Nearly two-fifths of Fortune 500 companies use Snowflake's software in the cloud as they move away from on-premise data warehousing products from<b>Teradata</b>(TDC),<b>Oracle</b>(ORCL) and<b>IBM</b>(IBM).</p><p><blockquote>近五分之二的财富 500 强公司在云中使用 Snowflake 软件，因为它们正在逐步淘汰本地数据仓库产品。<b>特拉达塔</b>（贸发局），<b>甲骨文</b>（ORCL）和<b>IBM</b>（IBM）。</blockquote></p><p> One Snowflake customer is pharma giant<b>Pfizer</b>(PFE). Pfizer uses Snowflake tools to forecast product sales and to gain insights into thedistribution of the Covid-19 vaccine.</p><p><blockquote>雪花客户之一是制药巨头<b>辉瑞</b>（PFE）。辉瑞使用雪花工具来预测产品销售，并深入了解新冠肺炎疫苗的分销情况。</blockquote></p><p> Snowflake Stock: Competition Increasing From Google Cloud?</p><p><blockquote>雪花股票：来自谷歌云的竞争加剧？</blockquote></p><p> Stellar customer growth enabled SNOW stock to pull off the largest initial public offering ever by a software company in September 2020. The IPO raised $3.4 billion.</p><p><blockquote>强劲的客户增长使 SNOW stock 于 2020 年 9 月完成了软件公司有史以来规模最大的首次公开募股。IPO筹集了34亿美元。</blockquote></p><p> But is Snowflake a buy right now? After a tough start to 2021, software growth stocks have rebounded. The iShares Expanded Tech-Software Sector ETF rose 5% in August, 3.4% in July and 8.7% in June.</p><p><blockquote>但是雪花现在值得购买吗？在经历了 2021 年的艰难开局后，软件成长型股票已经反弹。iShares 扩展科技软件行业 ETF 8 月份上涨 5%，7 月份上涨 3.4%，6 月份上涨 8.7%。</blockquote></p><p> Snowflake stock has out-performed the software sector since mid-May. It's up 13% in 2021.</p><p><blockquote>自五月中旬以来，雪花股票的表现一直优于软件板块。2021年增长13%。</blockquote></p><p> Snowflake stock hit an all-time high of 429 in early December last year. But SNOW stock swooned in late 2020 amid analyst concerns over its lofty valuation.</p><p><blockquote>去年 12 月初，雪花股票创下 429 点的历史新高。但由于分析师对其高估值的担忧，SNOW 股票在 2020 年底暴跌。</blockquote></p><p> At a June 10 analyst day, Snowflake laid out a path to $10 billion in product revenue by fiscal 2029, which coincides with calendar 2028. The $10 billion revenue target would result in a compound annual growth rate of 44%.</p><p><blockquote>在 6 月 10 日的分析师日上，Snowflake 制定了到 2029 财年实现 100 亿美元产品收入的路径，该财年与 2028 财年相吻合。100亿美元的收入目标将带来44%的复合年增长率。</blockquote></p><p> The company said it expects to increase the number of customers with over $1 million in product revenue. Snowflake also guided to long-term operating margin of 10%-plus, lower than some analysts expected.</p><p><blockquote>该公司表示，预计产品收入将超过 100 万美元，从而增加客户数量。Snowflake 还预计长期营业利润率将超过 10%，低于一些分析师的预期。</blockquote></p><p> Possible Threat From Amazon</p><p><blockquote>来自亚马逊的可能威胁</blockquote></p><p> Snowflake in July announced support for digital advertising standard Unified ID 2.0. Advertising is one of Snowflake's largest verticals with customers representing a large percentage of players in the space, noted a RBC Capital report. The move comes as Googlephases out internet cookies for targeted advertising.</p><p><blockquote>雪花在7月份宣布支持数字广告标准统一ID 2.0。加拿大皇家银行资本的一份报告指出，广告是雪花最大的垂直行业之一，客户在该领域占据了很大一部分。此举正值谷歌逐步淘汰用于定向广告的互联网cookies之际。</blockquote></p><p> Whether Amazon Web Services ratchets up competition remains a concern for SNOW stock. Plus, competition with privately held Databricks is heating up. A February funding roundvalued Databricks at $28 billion.</p><p><blockquote>亚马逊网络服务是否会加剧竞争仍然是 SNOW stock 关注的问题。此外，与私人持有的数据块的竞争正在白热化。2 月份的一笔融资使 Databricks 的估值达到 280 亿美元。</blockquote></p><p> Databricks, which usesartificial intelligence, is expected to launch its own IPO.<b>Hewlett Packard Enterprise</b>(HPE), with its GreenLake platform, is another rival.</p><p><blockquote>使用人工智能的Databricks预计将启动自己的IPO。<b>慧与</b>拥有 GreenLake 平台的 (HPE) 是另一个竞争对手。</blockquote></p><p> Snowflake stock bulls point to its seasoned management team as a strength no matter what unfolds.</p><p><blockquote>雪花股票的多头指出，无论发生什么，其经验丰富的管理团队都是一种优势。</blockquote></p><p> Two former Oracle engineers — Benoit Dageville and Thierry Cruanes — along with Marcin Zukowski, former chief executive of startup Vectorwise, started Snowflake in 2012. The company holds patents in database architecture, data warehouses and other areas.</p><p><blockquote>两名前甲骨文工程师——Benoit Dageville和Thierry Cruanes——以及初创公司Vectorwise的前首席执行官Marcin Zukowski于2012年创办了Snowflake。公司拥有数据库架构、数据仓库等领域的专利。</blockquote></p><p> SNOW Stock: ServiceNow Veterans Lead Company</p><p><blockquote>SNOW Stock：ServiceNow Veterans 牵头公司</blockquote></p><p> Snowflake brought inFrank Slootman as chief executive in May 2019. Slootman had stepped down as CEO of ServiceNow in early 2017. Former ServiceNow Chief Financial Officer Mike Scarpelli in 2019 also joined Snowflake in the same CFO position.</p><p><blockquote>Snowflake 于 2019 年 5 月任命 inFrank Slootman 为首席执行官。Slootman 已于 2017 年初辞去 ServiceNow 首席执行官一职。ServiceNow 前首席财务官 Mike Scarpelli 也于 2019 年加入 Snowflake，担任首席财务官一职。</blockquote></p><p> Unlike legacy, on-premise data management systems, Snowflake's platform was built from the ground up for cloud computing. It provides 100% of its software over the internet.</p><p><blockquote>与传统的本地数据管理系统不同，Snowflake的平台是为云计算从头开始构建的。它通过互联网提供100%的软件。</blockquote></p><p> Snowflake customers can share data with their partners across multiple online storage systems using the company's data warehouse. Snowflake also enables easily searchable data to be shared among applications.</p><p><blockquote>雪花客户可以使用公司的数据仓库，通过多个在线存储系统与合作伙伴共享数据。Snowflake还支持在应用程序之间共享易于搜索的数据。</blockquote></p><p> Snowflake's data analytics tools became available on Amazon Web Services in 2015, Microsoft's Azure in 2018 and on Google's cloud platform in 2020.</p><p><blockquote>雪花的数据分析工具于2015年在亚马逊网络服务上可用，2018年在微软的Azure上可用，2020年在谷歌云平台上可用。</blockquote></p><p> In June, Snowflake partnered with<b>C3.ai</b>(AI). The two companies will cooperate in offering artificial intelligence tools to companies.</p><p><blockquote>6月，雪花与<b>C3.艾</b>（人工智能）。两家公司将合作向企业提供人工智能工具。</blockquote></p><p> Amazon Web Services A 'Frenemy'</p><p><blockquote>亚马逊网络服务是“敌友”</blockquote></p><p> \"While Snowflake is multi-cloud, it derives some 85% of its revenues from data analytics jobs deployed on Amazon Web Services, which is also Snowflake's biggest rival with AWS Redshift,\" UBS analyst Karl Keirstead said in a recent note to clients.</p><p><blockquote>瑞银分析师 Karl Keirstead 在最近给客户的一份报告中表示：“虽然 Snowflake 是多云的，但其约 85% 的收入来自部署在亚马逊网络服务上的数据分析工作，亚马逊网络服务也是 Snowflake 与 AWS Redshift 的最大竞争对手。”</blockquote></p><p> \"This 'frenemy' relationship is critical to Snowflake's success,\" Keirstead went on to say. \"AWS benefits far more from Snowflake spending on compute and storage infrastructure resources than they lose in the form of foregone AWS Redshift revenues. Snowflake represents a dream customer and partner for AWS and Microsoft Azure.\"</p><p><blockquote>“这种‘敌友’关系对于雪花的成功至关重要，”基尔斯特德继续说道。“AWS 从 Snowflake 在计算和存储基础设施资源上的支出中获得的好处远远大于他们因放弃的 AWS 红移收入而损失的好处。Snowflake 代表了 AWS 和微软 Azure 的梦想客户和合作伙伴。”</blockquote></p><p></p><p> Snowflake has focused on six core markets, including financial services, health care and life sciences, retail and consumer packaged goods, advertising media and entertainment, technology, and the government sector.</p><p><blockquote>雪花专注于六个核心市场，包括金融服务、医疗保健和生命科学、零售和消费品包装、广告媒体和娱乐、技术以及政府部门。</blockquote></p><p> When Snowflake went public in September it used a dual-class share structure that gave its CEO and insiderssuper-voting rights. However, Snowflake eliminated the dual-class structure in March.</p><p><blockquote>当 Snowflake 在 9 月份上市时，它采用了双重股权结构，赋予其首席执行官和内部人士超级投票权。然而，雪花在3月份取消了双级结构。</blockquote></p><p> Snowflake had been based in San Mateo, Calif. Amid the shift to remote work spurred by the coronavirus emergency, Snowflake in May said it no longer has a corporate headquarters. It designated Bozeman, Mont., as its principal executive office. Slootman and Scarpelli are based in Bozeman.</p><p><blockquote>雪花公司总部设在加利福尼亚州的圣马特奥。在冠状病毒紧急情况下向远程工作的转变中，雪花在5月份表示，它不再有公司总部。它指定蒙大拿州波兹曼。，作为其主要执行办公室。斯洛特曼和斯卡佩利的总部设在波兹曼。</blockquote></p><p> Snowflake Stock Fundamental Analysis</p><p><blockquote>雪花股票基本面分析</blockquote></p><p> Software stocks typically trade as a multiple of forward-looking revenue growth. Software-as-a-service, or SaaS, companies, such as<b>Salesforce.com</b>(CRM), typically provide the highest revenue growth. Salesforce is a key marketing partner of SNOW stock.</p><p><blockquote>软件股通常以前瞻性收入增长的倍数进行交易。软件即服务（SaaS）公司，例如<b>销售力量网站</b>（CRM），通常提供最高的收入增长。Salesforce 是 SNOW stock 的主要营销合作伙伴。</blockquote></p><p> Snowflake also partners with consulting firms such as Deloitte and information technology firms such as privately held Informatica.</p><p><blockquote>Snowflake还与德勤等咨询公司和私人控股的Informatica等信息技术公司合作。</blockquote></p><p> Snowflake is not an SaaS company, however. Instead, it uses a consumption-based business model based on how much data its customers crunch and store.</p><p><blockquote>然而，雪花不是一家SaaS公司。相反，它使用基于消费的商业模式，基于客户处理和存储的数据量。</blockquote></p><p> Snowflake's revenue growth stands out. But there's less transparency and predictability than with subscription-based, recurring-revenue SaaS business models, analysts say.</p><p><blockquote>雪花的收入增长脱颖而出。但分析师表示，与基于订阅的经常性收入 SaaS 商业模式相比，透明度和可预测性较低。</blockquote></p><p> \"SNOW has a consumption model, whereby customers contract for a certain amount of compute and storage capacity,\" Mizuho Securities analyst Gregg Moskowitz said in a note. \"The company only records revenue, however, as that capacity is used, so there can be a lag of several months or more before revenue recognition begins.\"</p><p><blockquote>瑞穗证券分析师格雷格·莫斯科维茨在一份报告中表示：“SNOW 有一个消费模式，客户通过该模式签订一定数量的计算和存储容量合同。”“然而，该公司仅在产能被使用时才记录收入，因此在收入确认开始之前可能会有几个月或更长时间的滞后。”</blockquote></p><p> Snowflake is nearing an annual revenue run-rate of $1 billion. That's a big milestone for software growth companies. But SNOW stock is unprofitable on the two most common accounting standards.</p><p><blockquote>Snowflake 的年收入已接近 10 亿美元。这对于软件成长型公司来说是一个重要的里程碑。但根据两种最常见的会计准则，SNOW stock 是无利可图的。</blockquote></p><p> Many software companies are unprofitable using GAAP earnings, or generally accepted accounting principles, which includes stock-based compensation. But they're profitable on a non-GAAP or \"adjusted\" earnings basis.</p><p><blockquote>许多软件公司使用 GAAP 收益或普遍接受的会计原则（包括基于股票的薪酬）是无利可图的。但它们在非 GAAP 或“调整后”收益基础上是盈利的。</blockquote></p><p> Snowflake Stock Gains Traction In Large Deals</p><p><blockquote>雪花股票在大宗交易中获得吸引力</blockquote></p><p> Snowflake's July quarter decelerated from the previous quarter but topped analyst estimates as it gained traction with large deals in the financial services and healthcare markets.</p><p><blockquote>Snowflake 7 月份季度的业绩比上一季度有所放缓，但由于金融服务和医疗保健市场的大宗交易获得了牵引力，超出了分析师的预期。</blockquote></p><p> Snowflake said July-quarter revenue jumped 104% to $272.2 million from a year earlier. Analysts had estimated Snowflake revenue of $256.5 million.</p><p><blockquote>Snowflake 表示，7 月份季度收入同比增长 104%，达到 2.722 亿美元。分析师预计 Snowflake 的收入为 2.565 亿美元。</blockquote></p><p> Snowflake sales soared 110% in the April quarter and 117% in the January quarter.</p><p><blockquote>雪花销售额在 4 月份季度飙升 110%，在 1 月份季度飙升 117%。</blockquote></p><p> The provider of cloud-based data analytics software said product revenue rose 103% to $254.6 million vs. estimates of $240 million.</p><p><blockquote>这家基于云的数据分析软件提供商表示，产品收入增长了103%，达到2.546亿美元，而预期为2.4亿美元。</blockquote></p><p> In addition, Snowflake said it now has 116 customers with \"trailing 12-month product revenue greater than $1 million,\" up from 104 such customers as of April 30.</p><p><blockquote>此外，Snowflake 表示，目前有 116 名客户“过去 12 个月的产品收入超过 100 万美元”，而截至 4 月 30 日，此类客户为 104 名。</blockquote></p><p> \"SNOW stock ended the quarter with 12 net new $1 million-plus customers (vs. 27 last quarter, 8 a year ago), bringing total $1 million-plus customers to 116,\" said Cowen analyst J. Derrick Wood in a report. \"Management cited strength come from rising deal sizes, strong competitive win rates, high sales productivity levels and balanced demand across geographies, customer segments and verticals. SNOW's recent vertically-focused, go-to-market initiatives are resonating particularly well in financial services and healthcare.\"</p><p><blockquote>Cowen 分析师 J. Derrick Wood 在一份报告中表示：“本季度末，SNOW stock 净增 12 个 100 万美元以上的新客户（上季度为 27 个，去年同期为 8 个），使 100 万美元以上的客户总数达到 116 个。”“管理层认为，优势来自不断增长的交易规模、强劲的竞争胜率、高销售生产力水平以及跨地域、客户群和垂直领域的平衡需求。SNOW 最近专注于垂直领域的市场推广计划在金融服务和医疗保健领域引起了特别好的共鸣。”</blockquote></p><p> For the October quarter, Snowflake forecast product revenue in a range of $280 million to $285 million, above estimates of $270.5 million.</p><p><blockquote>对于 10 月份季度，Snowflake 预计产品收入将在 2.8 亿至 2.85 亿美元之间，高于 2.705 亿美元的预期。</blockquote></p><p> SNOW Stock Technical Analysis</p><p><blockquote>雪股技术分析</blockquote></p><p> Snowflake stock went public on Sept. 16, 2020, at 120 a share. At the time, software growth stocks were hot as investors sought recurring revenue amid the coronavirus emergency.</p><p><blockquote>Snowflake 股票于 2020 年 9 月 16 日上市，每股价格为 120 美元。当时，由于投资者在冠状病毒紧急情况下寻求经常性收入，软件成长型股票炙手可热。</blockquote></p><p> SNOW stock popped as high as 319 on the first day of trading and closed 111.6% above the IPO price at 253.93. Shares pulled back as analysts debated Snowflake's valuation.</p><p><blockquote>SNOW 股票首日交易高达 319 点，收盘价较 IPO 价格上涨 111.6%，报 253.93 点。由于分析师对 Snowflake 的估值展开辩论，股价回落。</blockquote></p><p> Snowflake stock forged acup-with-handle baseover the next two months. The new base created an entry point of 301. SNOW stock blew past the buy point, hitting an all-time high of 429 on Dec. 8.</p><p><blockquote>雪花股票在接下来的两个月里锻造了带手柄的针尖底座。新基地创建了301的入口点。SNOW 股价突破买入点，12 月 8 日创下 429 点的历史新高。</blockquote></p><p> Snowflake stock swooned in late 2020 amid questions over its valuation even as the IBD Computer-Software Enterprise group stayed resilient. The Computer-Software Enterprise group did not break down until mid-February amid a market rotation to value.</p><p><blockquote>尽管 IBD 计算机软件企业集团保持弹性，但由于对其估值的质疑，Snowflake 股票在 2020 年底暴跌。这家计算机软件企业集团直到二月中旬才在市场价值轮动中倒闭。</blockquote></p><p> Snowflake stock hit a 12-month low of 184.71 on May 13.</p><p><blockquote>5月13日，Snowflake股价触及184.71点的12个月低点。</blockquote></p><p> Is Snowflake Stock A Buy Right Now?</p><p><blockquote>雪花股票现在值得买入吗？</blockquote></p><p> Snowflake stock still trades at a substantial premium as a multiple of forward-looking revenue growth. SNOW stock holds anIBD Composite Ratingof 53 out of a best possible 99, according toIBD Stock Checkup.</p><p><blockquote>由于前瞻性收入增长的倍数，Snowflake 股票的交易价格仍然大幅溢价。根据 IBD 股票检查，SNOW 股票的 IBD 综合评级为 53 分（满分 99 分）。</blockquote></p><p> IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.</p><p><blockquote>IBD的综合评级将五个独立的专有评级合并为一个易于使用的评级。最好的成长型股票的综合评级为 90 或更高。</blockquote></p><p></p><p> One bright spot is that Snowflake stock owns an Accumulation/Distribution Rating of B, according toIBD MarketSmithanalysis. That rating analyzes price and volume changes in a stock over the past 13 weeks of trading.</p><p><blockquote>根据 IBD MarketSmithanalysis 的数据，一个亮点是雪花股票的累积/分配评级为 B。该评级分析股票在过去 13 周交易中的价格和成交量变化。</blockquote></p><p> The rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling. Think of the C grade as neutral.</p><p><blockquote>该评级范围为 A+ 至 E，衡量机构对股票的买卖情况。A+表示机构大量买入；E意味着大量抛售。把C级想象成中性。</blockquote></p><p> SNOW stock has yet toform a basewith a proper entry point. Snowflake stock has clawed above its 50-day moving average. If it holds above the 50-day line that could kick-start the right side of a deep base.</p><p><blockquote>雪股尚未形成一个具有适当切入点的基础。Snowflake 股票已突破 50 天移动平均线。如果它保持在 50 日线上方，可能会启动深底的右侧。</blockquote></p><p></p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Snowflake Stock A Buy? Data Analytics Specialist Rides Cloud Computing Wave<blockquote>雪花股票值得买入吗？数据分析专家乘着云计算浪潮</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Snowflake Stock A Buy? Data Analytics Specialist Rides Cloud Computing Wave<blockquote>雪花股票值得买入吗？数据分析专家乘着云计算浪潮</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">investors</strong><span class=\"h-time small\">2021-10-01 08:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Think of Snowflake stock as a proxy on the torrid growth of cloud computing giants<b>Amazon.com</b>(AMZN),<b>Microsoft</b>(MSFT) and<b>Alphabet</b>'s (GOOGL) Google.</p><p><blockquote>将雪花股票视为云计算巨头快速增长的代表<b>亚马逊</b>（亚马逊），<b>微软</b>（MSFT）和<b>Alphabet</b>（GOOGL）谷歌。</blockquote></p><p> Many companies are turning to cloud computing services as part of \"digital transformation\" projects that aim to gain business insights from crunching massive volumes of data. The cloud computing titans offer their own data analytics and management tools.</p><p><blockquote>许多公司正在转向云计算服务，作为“数字化转型”项目的一部分，这些项目旨在从处理大量数据中获得业务洞察力。云计算巨头提供自己的数据分析和管理工具。</blockquote></p><p> In a \"coopetition\" model, thecloud giantsgive their customers a green light to buy<b>Snowflake</b>'s (SNOW) software. The reason is Snowflake's tools are better at some key tasks, such as letting companies compile, view, analyze and share massive amounts of data in an easy way.</p><p><blockquote>在“合作竞争”模式下，云巨头为客户购买开绿灯<b>雪花</b>的（雪）软件。原因是Snowflake的工具在一些关键任务上表现更好，比如让公司以简单的方式编译、查看、分析和共享海量数据。</blockquote></p><p> Nearly two-fifths of Fortune 500 companies use Snowflake's software in the cloud as they move away from on-premise data warehousing products from<b>Teradata</b>(TDC),<b>Oracle</b>(ORCL) and<b>IBM</b>(IBM).</p><p><blockquote>近五分之二的财富 500 强公司在云中使用 Snowflake 软件，因为它们正在逐步淘汰本地数据仓库产品。<b>特拉达塔</b>（贸发局），<b>甲骨文</b>（ORCL）和<b>IBM</b>（IBM）。</blockquote></p><p> One Snowflake customer is pharma giant<b>Pfizer</b>(PFE). Pfizer uses Snowflake tools to forecast product sales and to gain insights into thedistribution of the Covid-19 vaccine.</p><p><blockquote>雪花客户之一是制药巨头<b>辉瑞</b>（PFE）。辉瑞使用雪花工具来预测产品销售，并深入了解新冠肺炎疫苗的分销情况。</blockquote></p><p> Snowflake Stock: Competition Increasing From Google Cloud?</p><p><blockquote>雪花股票：来自谷歌云的竞争加剧？</blockquote></p><p> Stellar customer growth enabled SNOW stock to pull off the largest initial public offering ever by a software company in September 2020. The IPO raised $3.4 billion.</p><p><blockquote>强劲的客户增长使 SNOW stock 于 2020 年 9 月完成了软件公司有史以来规模最大的首次公开募股。IPO筹集了34亿美元。</blockquote></p><p> But is Snowflake a buy right now? After a tough start to 2021, software growth stocks have rebounded. The iShares Expanded Tech-Software Sector ETF rose 5% in August, 3.4% in July and 8.7% in June.</p><p><blockquote>但是雪花现在值得购买吗？在经历了 2021 年的艰难开局后，软件成长型股票已经反弹。iShares 扩展科技软件行业 ETF 8 月份上涨 5%，7 月份上涨 3.4%，6 月份上涨 8.7%。</blockquote></p><p> Snowflake stock has out-performed the software sector since mid-May. It's up 13% in 2021.</p><p><blockquote>自五月中旬以来，雪花股票的表现一直优于软件板块。2021年增长13%。</blockquote></p><p> Snowflake stock hit an all-time high of 429 in early December last year. But SNOW stock swooned in late 2020 amid analyst concerns over its lofty valuation.</p><p><blockquote>去年 12 月初，雪花股票创下 429 点的历史新高。但由于分析师对其高估值的担忧，SNOW 股票在 2020 年底暴跌。</blockquote></p><p> At a June 10 analyst day, Snowflake laid out a path to $10 billion in product revenue by fiscal 2029, which coincides with calendar 2028. The $10 billion revenue target would result in a compound annual growth rate of 44%.</p><p><blockquote>在 6 月 10 日的分析师日上，Snowflake 制定了到 2029 财年实现 100 亿美元产品收入的路径，该财年与 2028 财年相吻合。100亿美元的收入目标将带来44%的复合年增长率。</blockquote></p><p> The company said it expects to increase the number of customers with over $1 million in product revenue. Snowflake also guided to long-term operating margin of 10%-plus, lower than some analysts expected.</p><p><blockquote>该公司表示，预计产品收入将超过 100 万美元，从而增加客户数量。Snowflake 还预计长期营业利润率将超过 10%，低于一些分析师的预期。</blockquote></p><p> Possible Threat From Amazon</p><p><blockquote>来自亚马逊的可能威胁</blockquote></p><p> Snowflake in July announced support for digital advertising standard Unified ID 2.0. Advertising is one of Snowflake's largest verticals with customers representing a large percentage of players in the space, noted a RBC Capital report. The move comes as Googlephases out internet cookies for targeted advertising.</p><p><blockquote>雪花在7月份宣布支持数字广告标准统一ID 2.0。加拿大皇家银行资本的一份报告指出，广告是雪花最大的垂直行业之一，客户在该领域占据了很大一部分。此举正值谷歌逐步淘汰用于定向广告的互联网cookies之际。</blockquote></p><p> Whether Amazon Web Services ratchets up competition remains a concern for SNOW stock. Plus, competition with privately held Databricks is heating up. A February funding roundvalued Databricks at $28 billion.</p><p><blockquote>亚马逊网络服务是否会加剧竞争仍然是 SNOW stock 关注的问题。此外，与私人持有的数据块的竞争正在白热化。2 月份的一笔融资使 Databricks 的估值达到 280 亿美元。</blockquote></p><p> Databricks, which usesartificial intelligence, is expected to launch its own IPO.<b>Hewlett Packard Enterprise</b>(HPE), with its GreenLake platform, is another rival.</p><p><blockquote>使用人工智能的Databricks预计将启动自己的IPO。<b>慧与</b>拥有 GreenLake 平台的 (HPE) 是另一个竞争对手。</blockquote></p><p> Snowflake stock bulls point to its seasoned management team as a strength no matter what unfolds.</p><p><blockquote>雪花股票的多头指出，无论发生什么，其经验丰富的管理团队都是一种优势。</blockquote></p><p> Two former Oracle engineers — Benoit Dageville and Thierry Cruanes — along with Marcin Zukowski, former chief executive of startup Vectorwise, started Snowflake in 2012. The company holds patents in database architecture, data warehouses and other areas.</p><p><blockquote>两名前甲骨文工程师——Benoit Dageville和Thierry Cruanes——以及初创公司Vectorwise的前首席执行官Marcin Zukowski于2012年创办了Snowflake。公司拥有数据库架构、数据仓库等领域的专利。</blockquote></p><p> SNOW Stock: ServiceNow Veterans Lead Company</p><p><blockquote>SNOW Stock：ServiceNow Veterans 牵头公司</blockquote></p><p> Snowflake brought inFrank Slootman as chief executive in May 2019. Slootman had stepped down as CEO of ServiceNow in early 2017. Former ServiceNow Chief Financial Officer Mike Scarpelli in 2019 also joined Snowflake in the same CFO position.</p><p><blockquote>Snowflake 于 2019 年 5 月任命 inFrank Slootman 为首席执行官。Slootman 已于 2017 年初辞去 ServiceNow 首席执行官一职。ServiceNow 前首席财务官 Mike Scarpelli 也于 2019 年加入 Snowflake，担任首席财务官一职。</blockquote></p><p> Unlike legacy, on-premise data management systems, Snowflake's platform was built from the ground up for cloud computing. It provides 100% of its software over the internet.</p><p><blockquote>与传统的本地数据管理系统不同，Snowflake的平台是为云计算从头开始构建的。它通过互联网提供100%的软件。</blockquote></p><p> Snowflake customers can share data with their partners across multiple online storage systems using the company's data warehouse. Snowflake also enables easily searchable data to be shared among applications.</p><p><blockquote>雪花客户可以使用公司的数据仓库，通过多个在线存储系统与合作伙伴共享数据。Snowflake还支持在应用程序之间共享易于搜索的数据。</blockquote></p><p> Snowflake's data analytics tools became available on Amazon Web Services in 2015, Microsoft's Azure in 2018 and on Google's cloud platform in 2020.</p><p><blockquote>雪花的数据分析工具于2015年在亚马逊网络服务上可用，2018年在微软的Azure上可用，2020年在谷歌云平台上可用。</blockquote></p><p> In June, Snowflake partnered with<b>C3.ai</b>(AI). The two companies will cooperate in offering artificial intelligence tools to companies.</p><p><blockquote>6月，雪花与<b>C3.艾</b>（人工智能）。两家公司将合作向企业提供人工智能工具。</blockquote></p><p> Amazon Web Services A 'Frenemy'</p><p><blockquote>亚马逊网络服务是“敌友”</blockquote></p><p> \"While Snowflake is multi-cloud, it derives some 85% of its revenues from data analytics jobs deployed on Amazon Web Services, which is also Snowflake's biggest rival with AWS Redshift,\" UBS analyst Karl Keirstead said in a recent note to clients.</p><p><blockquote>瑞银分析师 Karl Keirstead 在最近给客户的一份报告中表示：“虽然 Snowflake 是多云的，但其约 85% 的收入来自部署在亚马逊网络服务上的数据分析工作，亚马逊网络服务也是 Snowflake 与 AWS Redshift 的最大竞争对手。”</blockquote></p><p> \"This 'frenemy' relationship is critical to Snowflake's success,\" Keirstead went on to say. \"AWS benefits far more from Snowflake spending on compute and storage infrastructure resources than they lose in the form of foregone AWS Redshift revenues. Snowflake represents a dream customer and partner for AWS and Microsoft Azure.\"</p><p><blockquote>“这种‘敌友’关系对于雪花的成功至关重要，”基尔斯特德继续说道。“AWS 从 Snowflake 在计算和存储基础设施资源上的支出中获得的好处远远大于他们因放弃的 AWS 红移收入而损失的好处。Snowflake 代表了 AWS 和微软 Azure 的梦想客户和合作伙伴。”</blockquote></p><p></p><p> Snowflake has focused on six core markets, including financial services, health care and life sciences, retail and consumer packaged goods, advertising media and entertainment, technology, and the government sector.</p><p><blockquote>雪花专注于六个核心市场，包括金融服务、医疗保健和生命科学、零售和消费品包装、广告媒体和娱乐、技术以及政府部门。</blockquote></p><p> When Snowflake went public in September it used a dual-class share structure that gave its CEO and insiderssuper-voting rights. However, Snowflake eliminated the dual-class structure in March.</p><p><blockquote>当 Snowflake 在 9 月份上市时，它采用了双重股权结构，赋予其首席执行官和内部人士超级投票权。然而，雪花在3月份取消了双级结构。</blockquote></p><p> Snowflake had been based in San Mateo, Calif. Amid the shift to remote work spurred by the coronavirus emergency, Snowflake in May said it no longer has a corporate headquarters. It designated Bozeman, Mont., as its principal executive office. Slootman and Scarpelli are based in Bozeman.</p><p><blockquote>雪花公司总部设在加利福尼亚州的圣马特奥。在冠状病毒紧急情况下向远程工作的转变中，雪花在5月份表示，它不再有公司总部。它指定蒙大拿州波兹曼。，作为其主要执行办公室。斯洛特曼和斯卡佩利的总部设在波兹曼。</blockquote></p><p> Snowflake Stock Fundamental Analysis</p><p><blockquote>雪花股票基本面分析</blockquote></p><p> Software stocks typically trade as a multiple of forward-looking revenue growth. Software-as-a-service, or SaaS, companies, such as<b>Salesforce.com</b>(CRM), typically provide the highest revenue growth. Salesforce is a key marketing partner of SNOW stock.</p><p><blockquote>软件股通常以前瞻性收入增长的倍数进行交易。软件即服务（SaaS）公司，例如<b>销售力量网站</b>（CRM），通常提供最高的收入增长。Salesforce 是 SNOW stock 的主要营销合作伙伴。</blockquote></p><p> Snowflake also partners with consulting firms such as Deloitte and information technology firms such as privately held Informatica.</p><p><blockquote>Snowflake还与德勤等咨询公司和私人控股的Informatica等信息技术公司合作。</blockquote></p><p> Snowflake is not an SaaS company, however. Instead, it uses a consumption-based business model based on how much data its customers crunch and store.</p><p><blockquote>然而，雪花不是一家SaaS公司。相反，它使用基于消费的商业模式，基于客户处理和存储的数据量。</blockquote></p><p> Snowflake's revenue growth stands out. But there's less transparency and predictability than with subscription-based, recurring-revenue SaaS business models, analysts say.</p><p><blockquote>雪花的收入增长脱颖而出。但分析师表示，与基于订阅的经常性收入 SaaS 商业模式相比，透明度和可预测性较低。</blockquote></p><p> \"SNOW has a consumption model, whereby customers contract for a certain amount of compute and storage capacity,\" Mizuho Securities analyst Gregg Moskowitz said in a note. \"The company only records revenue, however, as that capacity is used, so there can be a lag of several months or more before revenue recognition begins.\"</p><p><blockquote>瑞穗证券分析师格雷格·莫斯科维茨在一份报告中表示：“SNOW 有一个消费模式，客户通过该模式签订一定数量的计算和存储容量合同。”“然而，该公司仅在产能被使用时才记录收入，因此在收入确认开始之前可能会有几个月或更长时间的滞后。”</blockquote></p><p> Snowflake is nearing an annual revenue run-rate of $1 billion. That's a big milestone for software growth companies. But SNOW stock is unprofitable on the two most common accounting standards.</p><p><blockquote>Snowflake 的年收入已接近 10 亿美元。这对于软件成长型公司来说是一个重要的里程碑。但根据两种最常见的会计准则，SNOW stock 是无利可图的。</blockquote></p><p> Many software companies are unprofitable using GAAP earnings, or generally accepted accounting principles, which includes stock-based compensation. But they're profitable on a non-GAAP or \"adjusted\" earnings basis.</p><p><blockquote>许多软件公司使用 GAAP 收益或普遍接受的会计原则（包括基于股票的薪酬）是无利可图的。但它们在非 GAAP 或“调整后”收益基础上是盈利的。</blockquote></p><p> Snowflake Stock Gains Traction In Large Deals</p><p><blockquote>雪花股票在大宗交易中获得吸引力</blockquote></p><p> Snowflake's July quarter decelerated from the previous quarter but topped analyst estimates as it gained traction with large deals in the financial services and healthcare markets.</p><p><blockquote>Snowflake 7 月份季度的业绩比上一季度有所放缓，但由于金融服务和医疗保健市场的大宗交易获得了牵引力，超出了分析师的预期。</blockquote></p><p> Snowflake said July-quarter revenue jumped 104% to $272.2 million from a year earlier. Analysts had estimated Snowflake revenue of $256.5 million.</p><p><blockquote>Snowflake 表示，7 月份季度收入同比增长 104%，达到 2.722 亿美元。分析师预计 Snowflake 的收入为 2.565 亿美元。</blockquote></p><p> Snowflake sales soared 110% in the April quarter and 117% in the January quarter.</p><p><blockquote>雪花销售额在 4 月份季度飙升 110%，在 1 月份季度飙升 117%。</blockquote></p><p> The provider of cloud-based data analytics software said product revenue rose 103% to $254.6 million vs. estimates of $240 million.</p><p><blockquote>这家基于云的数据分析软件提供商表示，产品收入增长了103%，达到2.546亿美元，而预期为2.4亿美元。</blockquote></p><p> In addition, Snowflake said it now has 116 customers with \"trailing 12-month product revenue greater than $1 million,\" up from 104 such customers as of April 30.</p><p><blockquote>此外，Snowflake 表示，目前有 116 名客户“过去 12 个月的产品收入超过 100 万美元”，而截至 4 月 30 日，此类客户为 104 名。</blockquote></p><p> \"SNOW stock ended the quarter with 12 net new $1 million-plus customers (vs. 27 last quarter, 8 a year ago), bringing total $1 million-plus customers to 116,\" said Cowen analyst J. Derrick Wood in a report. \"Management cited strength come from rising deal sizes, strong competitive win rates, high sales productivity levels and balanced demand across geographies, customer segments and verticals. SNOW's recent vertically-focused, go-to-market initiatives are resonating particularly well in financial services and healthcare.\"</p><p><blockquote>Cowen 分析师 J. Derrick Wood 在一份报告中表示：“本季度末，SNOW stock 净增 12 个 100 万美元以上的新客户（上季度为 27 个，去年同期为 8 个），使 100 万美元以上的客户总数达到 116 个。”“管理层认为，优势来自不断增长的交易规模、强劲的竞争胜率、高销售生产力水平以及跨地域、客户群和垂直领域的平衡需求。SNOW 最近专注于垂直领域的市场推广计划在金融服务和医疗保健领域引起了特别好的共鸣。”</blockquote></p><p> For the October quarter, Snowflake forecast product revenue in a range of $280 million to $285 million, above estimates of $270.5 million.</p><p><blockquote>对于 10 月份季度，Snowflake 预计产品收入将在 2.8 亿至 2.85 亿美元之间，高于 2.705 亿美元的预期。</blockquote></p><p> SNOW Stock Technical Analysis</p><p><blockquote>雪股技术分析</blockquote></p><p> Snowflake stock went public on Sept. 16, 2020, at 120 a share. At the time, software growth stocks were hot as investors sought recurring revenue amid the coronavirus emergency.</p><p><blockquote>Snowflake 股票于 2020 年 9 月 16 日上市，每股价格为 120 美元。当时，由于投资者在冠状病毒紧急情况下寻求经常性收入，软件成长型股票炙手可热。</blockquote></p><p> SNOW stock popped as high as 319 on the first day of trading and closed 111.6% above the IPO price at 253.93. Shares pulled back as analysts debated Snowflake's valuation.</p><p><blockquote>SNOW 股票首日交易高达 319 点，收盘价较 IPO 价格上涨 111.6%，报 253.93 点。由于分析师对 Snowflake 的估值展开辩论，股价回落。</blockquote></p><p> Snowflake stock forged acup-with-handle baseover the next two months. The new base created an entry point of 301. SNOW stock blew past the buy point, hitting an all-time high of 429 on Dec. 8.</p><p><blockquote>雪花股票在接下来的两个月里锻造了带手柄的针尖底座。新基地创建了301的入口点。SNOW 股价突破买入点，12 月 8 日创下 429 点的历史新高。</blockquote></p><p> Snowflake stock swooned in late 2020 amid questions over its valuation even as the IBD Computer-Software Enterprise group stayed resilient. The Computer-Software Enterprise group did not break down until mid-February amid a market rotation to value.</p><p><blockquote>尽管 IBD 计算机软件企业集团保持弹性，但由于对其估值的质疑，Snowflake 股票在 2020 年底暴跌。这家计算机软件企业集团直到二月中旬才在市场价值轮动中倒闭。</blockquote></p><p> Snowflake stock hit a 12-month low of 184.71 on May 13.</p><p><blockquote>5月13日，Snowflake股价触及184.71点的12个月低点。</blockquote></p><p> Is Snowflake Stock A Buy Right Now?</p><p><blockquote>雪花股票现在值得买入吗？</blockquote></p><p> Snowflake stock still trades at a substantial premium as a multiple of forward-looking revenue growth. SNOW stock holds anIBD Composite Ratingof 53 out of a best possible 99, according toIBD Stock Checkup.</p><p><blockquote>由于前瞻性收入增长的倍数，Snowflake 股票的交易价格仍然大幅溢价。根据 IBD 股票检查，SNOW 股票的 IBD 综合评级为 53 分（满分 99 分）。</blockquote></p><p> IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.</p><p><blockquote>IBD的综合评级将五个独立的专有评级合并为一个易于使用的评级。最好的成长型股票的综合评级为 90 或更高。</blockquote></p><p></p><p> One bright spot is that Snowflake stock owns an Accumulation/Distribution Rating of B, according toIBD MarketSmithanalysis. That rating analyzes price and volume changes in a stock over the past 13 weeks of trading.</p><p><blockquote>根据 IBD MarketSmithanalysis 的数据，一个亮点是雪花股票的累积/分配评级为 B。该评级分析股票在过去 13 周交易中的价格和成交量变化。</blockquote></p><p> The rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling. Think of the C grade as neutral.</p><p><blockquote>该评级范围为 A+ 至 E，衡量机构对股票的买卖情况。A+表示机构大量买入；E意味着大量抛售。把C级想象成中性。</blockquote></p><p> SNOW stock has yet toform a basewith a proper entry point. Snowflake stock has clawed above its 50-day moving average. If it holds above the 50-day line that could kick-start the right side of a deep base.</p><p><blockquote>雪股尚未形成一个具有适当切入点的基础。Snowflake 股票已突破 50 天移动平均线。如果它保持在 50 日线上方，可能会启动深底的右侧。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investors.com/news/technology/snowflake-snow-stock-buy-now/?src=A00220\">investors</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"source_url":"https://investors.com/news/technology/snowflake-snow-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155834484","content_text":"Think of Snowflake stock as a proxy on the torrid growth of cloud computing giantsAmazon.com(AMZN),Microsoft(MSFT) andAlphabet's (GOOGL) Google.\nMany companies are turning to cloud computing services as part of \"digital transformation\" projects that aim to gain business insights from crunching massive volumes of data. The cloud computing titans offer their own data analytics and management tools.\nIn a \"coopetition\" model, thecloud giantsgive their customers a green light to buySnowflake's (SNOW) software. The reason is Snowflake's tools are better at some key tasks, such as letting companies compile, view, analyze and share massive amounts of data in an easy way.\nNearly two-fifths of Fortune 500 companies use Snowflake's software in the cloud as they move away from on-premise data warehousing products fromTeradata(TDC),Oracle(ORCL) andIBM(IBM).\nOne Snowflake customer is pharma giantPfizer(PFE). Pfizer uses Snowflake tools to forecast product sales and to gain insights into thedistribution of the Covid-19 vaccine.\nSnowflake Stock: Competition Increasing From Google Cloud?\nStellar customer growth enabled SNOW stock to pull off the largest initial public offering ever by a software company in September 2020. The IPO raised $3.4 billion.\nBut is Snowflake a buy right now? After a tough start to 2021, software growth stocks have rebounded. The iShares Expanded Tech-Software Sector ETF rose 5% in August, 3.4% in July and 8.7% in June.\nSnowflake stock has out-performed the software sector since mid-May. It's up 13% in 2021.\nSnowflake stock hit an all-time high of 429 in early December last year. But SNOW stock swooned in late 2020 amid analyst concerns over its lofty valuation.\nAt a June 10 analyst day, Snowflake laid out a path to $10 billion in product revenue by fiscal 2029, which coincides with calendar 2028. The $10 billion revenue target would result in a compound annual growth rate of 44%.\nThe company said it expects to increase the number of customers with over $1 million in product revenue. Snowflake also guided to long-term operating margin of 10%-plus, lower than some analysts expected.\nPossible Threat From Amazon\nSnowflake in July announced support for digital advertising standard Unified ID 2.0. Advertising is one of Snowflake's largest verticals with customers representing a large percentage of players in the space, noted a RBC Capital report. The move comes as Googlephases out internet cookies for targeted advertising.\nWhether Amazon Web Services ratchets up competition remains a concern for SNOW stock. Plus, competition with privately held Databricks is heating up. A February funding roundvalued Databricks at $28 billion.\nDatabricks, which usesartificial intelligence, is expected to launch its own IPO.Hewlett Packard Enterprise(HPE), with its GreenLake platform, is another rival.\nSnowflake stock bulls point to its seasoned management team as a strength no matter what unfolds.\nTwo former Oracle engineers — Benoit Dageville and Thierry Cruanes — along with Marcin Zukowski, former chief executive of startup Vectorwise, started Snowflake in 2012. The company holds patents in database architecture, data warehouses and other areas.\nSNOW Stock: ServiceNow Veterans Lead Company\nSnowflake brought inFrank Slootman as chief executive in May 2019. Slootman had stepped down as CEO of ServiceNow in early 2017. Former ServiceNow Chief Financial Officer Mike Scarpelli in 2019 also joined Snowflake in the same CFO position.\nUnlike legacy, on-premise data management systems, Snowflake's platform was built from the ground up for cloud computing. It provides 100% of its software over the internet.\nSnowflake customers can share data with their partners across multiple online storage systems using the company's data warehouse. Snowflake also enables easily searchable data to be shared among applications.\nSnowflake's data analytics tools became available on Amazon Web Services in 2015, Microsoft's Azure in 2018 and on Google's cloud platform in 2020.\nIn June, Snowflake partnered withC3.ai(AI). The two companies will cooperate in offering artificial intelligence tools to companies.\nAmazon Web Services A 'Frenemy'\n\"While Snowflake is multi-cloud, it derives some 85% of its revenues from data analytics jobs deployed on Amazon Web Services, which is also Snowflake's biggest rival with AWS Redshift,\" UBS analyst Karl Keirstead said in a recent note to clients.\n\"This 'frenemy' relationship is critical to Snowflake's success,\" Keirstead went on to say. \"AWS benefits far more from Snowflake spending on compute and storage infrastructure resources than they lose in the form of foregone AWS Redshift revenues. Snowflake represents a dream customer and partner for AWS and Microsoft Azure.\"\nSnowflake has focused on six core markets, including financial services, health care and life sciences, retail and consumer packaged goods, advertising media and entertainment, technology, and the government sector.\nWhen Snowflake went public in September it used a dual-class share structure that gave its CEO and insiderssuper-voting rights. However, Snowflake eliminated the dual-class structure in March.\nSnowflake had been based in San Mateo, Calif. Amid the shift to remote work spurred by the coronavirus emergency, Snowflake in May said it no longer has a corporate headquarters. It designated Bozeman, Mont., as its principal executive office. Slootman and Scarpelli are based in Bozeman.\nSnowflake Stock Fundamental Analysis\nSoftware stocks typically trade as a multiple of forward-looking revenue growth. Software-as-a-service, or SaaS, companies, such asSalesforce.com(CRM), typically provide the highest revenue growth. Salesforce is a key marketing partner of SNOW stock.\nSnowflake also partners with consulting firms such as Deloitte and information technology firms such as privately held Informatica.\nSnowflake is not an SaaS company, however. Instead, it uses a consumption-based business model based on how much data its customers crunch and store.\nSnowflake's revenue growth stands out. But there's less transparency and predictability than with subscription-based, recurring-revenue SaaS business models, analysts say.\n\"SNOW has a consumption model, whereby customers contract for a certain amount of compute and storage capacity,\" Mizuho Securities analyst Gregg Moskowitz said in a note. \"The company only records revenue, however, as that capacity is used, so there can be a lag of several months or more before revenue recognition begins.\"\nSnowflake is nearing an annual revenue run-rate of $1 billion. That's a big milestone for software growth companies. But SNOW stock is unprofitable on the two most common accounting standards.\nMany software companies are unprofitable using GAAP earnings, or generally accepted accounting principles, which includes stock-based compensation. But they're profitable on a non-GAAP or \"adjusted\" earnings basis.\nSnowflake Stock Gains Traction In Large Deals\nSnowflake's July quarter decelerated from the previous quarter but topped analyst estimates as it gained traction with large deals in the financial services and healthcare markets.\nSnowflake said July-quarter revenue jumped 104% to $272.2 million from a year earlier. Analysts had estimated Snowflake revenue of $256.5 million.\nSnowflake sales soared 110% in the April quarter and 117% in the January quarter.\nThe provider of cloud-based data analytics software said product revenue rose 103% to $254.6 million vs. estimates of $240 million.\nIn addition, Snowflake said it now has 116 customers with \"trailing 12-month product revenue greater than $1 million,\" up from 104 such customers as of April 30.\n\"SNOW stock ended the quarter with 12 net new $1 million-plus customers (vs. 27 last quarter, 8 a year ago), bringing total $1 million-plus customers to 116,\" said Cowen analyst J. Derrick Wood in a report. \"Management cited strength come from rising deal sizes, strong competitive win rates, high sales productivity levels and balanced demand across geographies, customer segments and verticals. SNOW's recent vertically-focused, go-to-market initiatives are resonating particularly well in financial services and healthcare.\"\nFor the October quarter, Snowflake forecast product revenue in a range of $280 million to $285 million, above estimates of $270.5 million.\nSNOW Stock Technical Analysis\nSnowflake stock went public on Sept. 16, 2020, at 120 a share. At the time, software growth stocks were hot as investors sought recurring revenue amid the coronavirus emergency.\nSNOW stock popped as high as 319 on the first day of trading and closed 111.6% above the IPO price at 253.93. Shares pulled back as analysts debated Snowflake's valuation.\nSnowflake stock forged acup-with-handle baseover the next two months. The new base created an entry point of 301. SNOW stock blew past the buy point, hitting an all-time high of 429 on Dec. 8.\nSnowflake stock swooned in late 2020 amid questions over its valuation even as the IBD Computer-Software Enterprise group stayed resilient. The Computer-Software Enterprise group did not break down until mid-February amid a market rotation to value.\nSnowflake stock hit a 12-month low of 184.71 on May 13.\nIs Snowflake Stock A Buy Right Now?\nSnowflake stock still trades at a substantial premium as a multiple of forward-looking revenue growth. SNOW stock holds anIBD Composite Ratingof 53 out of a best possible 99, according toIBD Stock Checkup.\nIBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.\nOne bright spot is that Snowflake stock owns an Accumulation/Distribution Rating of B, according toIBD MarketSmithanalysis. That rating analyzes price and volume changes in a stock over the past 13 weeks of trading.\nThe rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling. Think of the C grade as neutral.\nSNOW stock has yet toform a basewith a proper entry point. Snowflake stock has clawed above its 50-day moving average. If it holds above the 50-day line that could kick-start the right side of a deep base.","news_type":1,"symbols_score_info":{"SNOW":0.9}},"isVote":1,"tweetType":1,"viewCount":3033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}